VNDA - Vanda Pharmaceu Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (0.21%) NFLX (-0.86%) QQQ (0.12%) BIDU (2.72%) AGIO (-0.53%) CODX (-0.87%) ETHUSD (%) FB (0.14%) HOME (-6.63%) MDGL (-1.59%) MTP (-1.22%) NVDA (1.35%) TMO (0.39%) UBER (-1.11%) UGAZ (-1.84%) XEC (-0.95%) EBAY (0.14%) DO (0.38%) DISCA (-1.55%) DIS (0.31%) DFFN (0.39%) CUR (-9.79%) CRC (1.11%) CHMA (25.49%) CBAY (-2.54%)

Next Earnings Date : 7/31/2019

VNDA - Vanda Pharmaceutical...

$12.73 0.33[2.58%]

15 mins delayed data

People also watch :

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$12.41	Open	$12.50
Volume	136K	Market Cap	788.1M
Yield		Last Dividend

Day

52 Week

The Daily Biotech Pulse: Acadia Schizoph...	4:26 AM
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 22) ...

Vanda Pharmaceuticals to Announce Second...	07/22/19
Conference Call and Webcast to Follow WASHINGTON , July 22, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it ...

FDA points to deficiencies in Vanda'...	07/22/19
Vanda Pharmaceuticals Inc. disclosed a note from federal regulators that pointed to deficiencies in its latest application for approval for a jet lag ...

Vanda Pharmaceuticals FDA Update for HET...	07/22/19
WASHINGTON, July 22, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (VNDA) today announced that on July 19, 2019, it received a notification ...

How Do You Test a New Seasickness Drug? ...	07/18/19
(Bloomberg) -- Most drug trials take place in sterile hospital labs, universities or clinics. Vanda Pharmaceuticals Inc. decided a boat in the Pacific...

Nausea no more? D.C. biotech gets motion...	07/17/19
The company’s latest experimental drug was tested on more than 100 patients with motion sickness traveling on the Pacific Ocean.

Tradipitant Effective in Preventing Moti...	07/16/19
WASHINGTON , July 16, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that tradipitant, a neurokinin-1 receptor...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP...	07/16/19
NEW YORK, July 16, 2019 -- Levi & Korsinsky announces it has commenced an investigation of Vanda Pharmaceuticals Inc. (NASDAQGM: VNDA) concerning poss...

Is Vanda Pharmaceuticals Inc. (NASDAQ:VN...	07/08/19
Building up an investment case requires looking at a stock holistically. Today I've chosen to put the spotlight on...

ANALYST RATINGS

0 analyst ratings (Last 6 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	2019-05-01 (AMC)	Est. (EPS/Rev.)	$0.07/ 51.76M
Actual (EPS/Rev.)	$0.06/ $47.71 M	EPS (TTM)	0

TRADERS TRACKING $VNDA

Service Name	Trader	% Success
Swing for the fences	Gino Baldassano	79.00 %	Follow
Alpha Swing Trades	Jonathan	69.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.